Trans fatty acids and cardiovascular risk: A unique cardiometabolic imprint?

Current Atherosclerosis Reports

Volumn 9, Issue 6, 2007, Pages 486-493

  Mozaffarian, Dariush ^a   Willett, Walter C ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID; TRANS FATTY ACID;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATERING SERVICE; CONSUMER HEALTH INFORMATION; DIET RESTRICTION; DISEASE ASSOCIATION; FAT INTAKE; FOOD AND DRUG ADMINISTRATION; FOOD COMPOSITION; FOOD PROCESSING; HEART INFARCTION; HUMAN; INFLAMMATION; INFORMATION DISSEMINATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; NONHUMAN; OBESITY; OBSERVATIONAL STUDY; PRIMATE; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; UNITED STATES; VASCULAR ENDOTHELIUM;

ADIPOSE TISSUE; ANIMALS; DEATH, SUDDEN; DIABETES MELLITUS; DIETARY FATS; FOOD; HEALTH EDUCATION; HUMANS; HYDROGENATION; INSULIN RESISTANCE; LIPIDS; MYOCARDIAL INFARCTION; PLANT OILS; TRANS FATTY ACIDS;

EID: 38149012027     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-007-0065-9     Document Type: Review

References (50)

1. Lueck TJ, Severson K: New York bans most trans fats in restaurants. The New York Times. December 6, 2006; A1.
2. Eckel RH, Borra S, Lichtenstein AH, Yin-Piazza SY: Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation 2007, 115:2231-2246.
3. Craig-Schmidt MC: World-wide consumption of trans fatty acids. Atheroscler Suppl 2006, 7:1-4.
4. Allison DB, Egan SK, Barraj LM, et al.: Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999, 99:166-174.
5. Stender S, Dyerberg J, Astrup A: High levels of industrially produced trans fat in popular fast foods. N Engl J Med 2006, 354:1650-1652.
6. Dietary Guidelines Advisory Committee: 2005 Dietary Guidelines Advisory Committee Report. Available at http://www.health.gov/ dietaryguidelines/dga2005/report/. Accessed November 2, 2006.
7. Chardigny JM, Malpuech-Brugere C, Dionisi F, et al.: Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Contemp Clin Trials 2006, 27:364-373.
8. Jakobsen MU, Bysted A, Andersen NL, et al.: Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. Eur J Clin Nutr 2006, 60:312-318.
9. Oomen CM, Ocke MC, Feskens EJ, et al.: Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001, 357:746-751.
10. Pietinen P, Ascherio A, Korhonen P, et al.: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997, 145:876-887.
11. Willett WC, Stampfer MJ, Manson JE, et al.: Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341:581-585.
12. Mozaffarian D, Katan MB, Ascherio A, et al.: Trans fatty acids and cardiovascular disease. N Engl J Med 2006, 354:1601-1613.
13. Mozaffarian D, Pischon T, Hankinson SE, et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004, 79:606-612.
14. Lopez-Garcia E, Schulze MB, Meigs JB, et al.: Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005, 135:562-566.
15. Mozaffarian D, Rimm EB, King IB, et al.: Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 2004, 80:1521-1525.
16. Han SN, Leka LS, Lichtenstein AH, et al.: Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 2002, 43:445-452.
17. Baer DJ, Judd JT, Clevidence BA, Tracy RP: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004, 79:969-973.
18. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
19. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
20. Zapolska-Downar D, Kosmider A, Naruszewicz M: Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 2005, 56:611-625.
21. de Roos NM, Bots ML, Katan MB: Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001, 21:1233-1237.
22. Willett WC, Leibel RL: Dietary fat is not a major determinant of body fat. Am J Med 2002, 113(Suppl 9B):47S-59S.
23. Koh-Banerjee P, Chu NF, Spiegelman D, et al.: Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr 2003, 78:719-727.
24. Field AE, Willett WC, Lissner L, Colditz GA: Dietary fat and weight gain among women in the Nurses' Health Study. Obesity (Silver Spring) 2007, 15:967-976.
25. Kavanagh K, Jones KL, Sawyer J, et al.: Trans-fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity Res 2007, In press.
26. Louheranta AM, Turpeinen AK, Vidgren HM, et al.: A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metab Clin Exp 1999, 48:870-875.
27. Lovejoy JC, Smith SR, Champagne CM, et al.: Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002, 25:1283-1288.
28. Lefevre M, Lovejoy JC, Smith SR, et al.: Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metab Clin Exp 2005, 54:1652-1658.
29. Albuquerque KT, Sardinha FL, Telles MM, et al.: Intake of trans fatty acid-rich hydrogenated fat during pregnancy and lactation inhibits the hypophagic effect of central insulin in the adult offspring. Nutrition 2006, 22:820-829.
30. Innis SM: Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler Suppl 2006, 7:17-20.
31. Saravanan N, Haseeb A, Ehtesham NZ, Ghafoorunissa R: Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur J Endocrinol/Eur Federation Endocr Soc 2005, 153:159-165.
32. Niu SL, Mitchell DC, Litman BJ: Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005, 44:4458-4465.
33. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC: Dietary fatty acid intakes and the risk of ovulatory infertility. Am J Clin Nutr 2007, 85:231-237.
34. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Long-term intake of trans-fatty acids and risk of gallstone disease in men. Arch Inter Med 2005, 165:1011-1015.
35. Lemaitre RN, King IB, Mozaffarian D, et al.: Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the Cardiovascular Health Study. Circulation 2006, 114:209-215.
36. Harris WS, Reid KJ, Sands SA, Spertus JA: Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007, 99:154-158.
37. Sun Q, Ma J, Campos H, et al.: A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 2007, 115:1858-1865.
38. Roberts TL, Wood DA, Riemersma RA, et al.: Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 1995, 345:278-282.
39. Lemaitre RN, King IB, Raghunathan TE, et al.: Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002, 105:697-701.
40. van Dam RM, Rimm EB, Willett WC, et al.: Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002, 136:201-209.
41. Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR: Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001, 24:1528-1535.
42. Hu FB, Manson JE, Stampfer MJ, et al.: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001, 345:790-797.
43. Institute of Medicine: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: National Academy Press; 2005.
44. Leth T, Jensen HG, Mikkelsen AA, Bysted A: The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl 2006, 7:53-56.
45. Nielsen K: Is the quality and cost of food affected if industrially produced trans fatty acids are removed? Atheroscler Suppl 2006, 7:61-62.
46. Health Canada: Government response to the interim recommendations of the trans fat task force. Available at http://www.hc-sc.gc.ca/fn-an/ nutrition/gras-transfats/government_response_reponse_gouvernement_e.html. Accessed November 2, 2006.
47. Aro A: The scientific basis for trans fatty acid regulations-is it sufficient? A European perspective. Atheroscler Suppl 2006, 7:67-68.
48. North Carolina General Statutes, Chapter 115C: Elementary and Secondary Education. Available at http://www.ncga.state.nc.us/ enactedlegislation/statutes/html/bysection/chapter_115c/ gs_115c-264.html. Accessed November 2, 2006.
49. Center for Science in the Public Interest: Petition for rulemaking to revoke the authority for industry to use partially hydrogenated vegetable oils in foods. Available at http://cspinet.org/new/pdf/ trans_fat_petitiony_ma_18.Pdf. Accessed November 2, 2006.
50. Katan MB: Regulation of trans fats: the gap, the Polder, and McDonald's French fries. Atheroscler Suppl 2006, 7:63-66.